TRANPIRA Trademark

Trademark Overview

On Wednesday, March 27, 2013, a trademark application was filed for TRANPIRA with the United States Patent and Trademark Office. The USPTO has given the TRANPIRA trademark a serial number of 85888138. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 29, 2023. This trademark is owned by Glaxo Group Limited. The TRANPIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
tranpira

General Information

Serial Number85888138
Word MarkTRANPIRA
Filing DateWednesday, March 27, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 29, 2023
Registration Number5220604
Registration DateTuesday, June 13, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "TRANPIRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, December 29, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 13, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, May 11, 2017ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, April 4, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 14, 2016AMENDMENT AFTER NOA NOT ENTERED
Monday, March 20, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 11, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, September 14, 2016NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 14, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, March 23, 2016SOU EXTENSION 5 GRANTED
Thursday, March 3, 2016SOU EXTENSION 5 FILED
Thursday, March 3, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 10, 2015SOU EXTENSION 4 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 4 FILED
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 3, 2015SOU EXTENSION 3 GRANTED
Friday, March 27, 2015SOU EXTENSION 3 FILED
Friday, March 27, 2015SOU TEAS EXTENSION RECEIVED
Friday, October 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 16, 2014SOU EXTENSION 2 GRANTED
Tuesday, September 30, 2014SOU EXTENSION 2 FILED
Tuesday, October 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 30, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, March 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 24, 2014SOU EXTENSION 1 GRANTED
Monday, March 24, 2014SOU EXTENSION 1 FILED
Monday, March 24, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 8, 2013ASSIGNED TO EXAMINER
Tuesday, April 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 30, 2013NEW APPLICATION ENTERED

Related Keywords

tranpira pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological